Table 1.

Changes in predicted 10-year CHD risk in DEPLOY participants

	Community-based DPP				Control				Difference
	n	Mean ± SE*	95% CI	P†	n	Mean ± SE	95% CI	P†	Mean	95% CI	P‡
4 months	39	−3.28 ± 0.76	−4.79 to −1.77	<0.001	34	−0.78 ± 0.81	−2.40 to 0.84	0.339	−2.50	−4.73 to −0.28	0.028
12 months	29	−2.23 ± 1.05	−4.33 to −0.14	0.037	30	1.88 ± 1.03	−0.18 to 3.94	0.073	−4.11	−7.06 to −1.17	0.007

n = 46 for each group at baseline. At the 4- and 12-month follow-ups, the completion rates were 85 and 83%, respectively, for the intervention group and 63 and 72%, respectively, for the control group. However, for the control group, sufficient data to construct UKPDS risk scores were not available for four additional participants at 4 months and three additional participants at 12 months.

^*Estimates were adjusted for baseline CHD risk.

^†P values for change from baseline.

^‡P values for difference in change between groups.